Omni Health, Inc. (OMHE) Announces Upcoming Opening of Functional Medicine Clinic

Omni Health is in the process of leasing its first state of the art facility to offer high-end and convenient location in trendy South Miami area. The new facility will offer the latest anti-aging regenerative medicine solutions. The following are among treatments which will be available at the new clinic:

• Bioidentical hormone therapy
• Medical weight loss management
• Nutrient supplements
• Detoxification
• I.V. Nutritional Therapy
• Wellness coaching
• Therapies for insomnia, migraines, and stress
• Stem Cell Regeneration Treatments
• Aesthetic treatments such as Botox® and Juviderm® injections and laser hair removal

“With over 10 years’ experience in the field of anti-aging we are extremely pleased with this latest development to fulfill the ever-strong demand for anti-aging treatments,” said Andrey Soloviev, Omni Health’s CEO. “Anti-aging medicine is a rapidly growing field fueled not only by the growing population of retirees but by both males and females from significantly younger age groups. By being able to offer the full specter of anti-aging treatments we will fulfill our earlier promise to shareholders to position our Company as an emergent, dominant presence in key, lucrative markets.”

The market research firm Global Industry Analysts estimates that a boomer fueled consumer base “seeking to keep the dreaded signs of aging at bay” will push US market for anti-aging products and services from about $80 billion now to more than $114 billion by 2020.

The Company anticipates completing all necessary licensing requirements and begin operating the new facility in December 2018 with the ultimate goal of opening a network of such clinics nationwide and becoming a leader in anti-aging medicine and integrative health management. Company anticipates pro-forma annual revenue of $7,500,000 per clinic.

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.